Disease - Respiratory
Breathing Easier: Messages for Asthma Relief, 2003
Asthma is the most common chronic disease among children, and is the leading cause of school absences due to a chronic disease. This brief article, written in partnership with the Chronic Disease Directors and published by NAPS outlines key factors for consumers about asthma, its risk factors, diagnosis, and preventive measures.
A Closer Look at Allergies, 2001
Allergies are the sixth leading cause of chronic disease in the U.S., and cost the health care system over $18 billion annually. In this publication, a joint project between the Asthma and Allergy Foundation of America and NPC, we take a closer look factors influencing drug spending for allergies.
A Closer Look at Asthma, 2001
Asthma results in approximately 5,000 deaths annually in the U.S. and accounts for nearly half a million hospitalizations, 1.6 million emergency room visits, and over 10 million physician office visits. In this six-page brochure, a joint project between the Asthma and Allergy Foundation of America and NPC, we take a closer look at the factors influencing drug spending for the treatment of asthma.
Disease Management for Asthma, 2004
Asthma, one of the first disease management targets, is often selected for managed intervention because high-cost patients can be easily identified via their frequent medication refills, consistent clinical practice guidelines and validated outcome measures are available that can help assess the effectiveness of the interventions, and educational interventions have been
developed to help improve the behavior of both patients and health care practitioners. This bibliography presents 69 studies demonstrating the impact of educational interventions on asthma treatment and management. Fact sheet available.
Disease Management for Chronic Obstructive Pulmonary Disease, 2003
This bibliography of disease management and educational interventions focuses on a relatively new disease target for such programs, chronic
obstructive pulmonary disease (COPD). In the year 2000, an estimated 10 million Americans were diagnosed with COPD and another 14 million were undiagnosed. The high mortality and cost associated with COPD, as well as a lack of awareness regarding the disease, are incentives to apply disease management strategies. Further education of health care providers and the public could improve the detection and treatment of COPD.
The Health and Productivity Cost Burden of the “Top 10” Physical and Mental Health Conditions Affecting Six Large U.S. Employers, by Ron Z. Goetzel, et al., Journal of Occupational and Environmental Medicine, Vol. 45, No.1, January 2003
This article identifies the top 10 most costly physical and mental health conditions faced by six large employers in their health benefits programs. The research identifies costs associated with each condition including direct medical costs and the indirect costs associated with days absent from the job and short-term disability costs.
Health Care & Productivity, 2000
This newsletter, designed for employers, details how newer drug therapies have direct and profound effects on productivity and the bottom lines of employers who select and provide health benefits.
The Impact of Disease Management on Outcomes and Cost of Care: A Study of Low-Income Asthma Patients, by Louis F. Rossiter, et al.,
Inquiry, Vol. 37, No. 2, Summer 2000
This article chronicles how concerns about the health outcomes and costs of care for Medicaid recipients with chronic diseases has led to development of a model program to enhance the quality of care and reduce overall cost of care for Medicaid patients enrolled in Virginia's primary care case management program. Fact
sheet available.
Newness of Drugs and Use of HMO Services by Asthma Patients, by Susan D. Horn, et al., The Annals of Pharmacotherapy, Vol. 35, No. 9, September 2001
Analyses showed an association between greater use of newer asthma drugs and lower overall drug costs and physician visits. A trend was also found between greater use of newer asthma drugs and fewer hospitalizations and emergency department visits.
Pharmaceuticals and Productivity: Investing in Human Capital, 2001
(Note: ~20mb)
New therapies have the potential to produce economic savings and benefits both outside of the health care system (indirect savings) and within the system (direct savings). This report explores the question of whether spending on pharmaceuticals has a positive payoff.
The Silver Book: Chronic Disease and Medical Innovation in an Aging Nation
The Silver Book, a project of the Alliance for Aging Research is an almanac of hundreds of facts, statistics, graphs, and information from close to 100 agencies, organizations and experts. It is a searchable database that is constantly updated and expanded in order to highlight the latest research and data on the burden of chronic disease and the value of investing in medical research. The Silver Book database is searchable by specific terms or by sections. The database is also interactive, allowing users to submit data from additional studies and reports.
The Value of Disease Management: Balancing Cost and Quality in the Treatment of Asthma, by Jeann Lee Gillespie, PharmD, MS, Disease Management, Vol. 5, No. 4, 2002
Asthma is often selected for disease management programs because of its high prevalence and large economic impact and the frequent failure to provide appropriate patient care and achieve optimal outcomes. The article examines the value of disease management in both improving the quality of care received and managing costs associated with the treatment of asthma. Case studies from state Medicaid initiatives and private sector HMO programs are provided.
The Virginia Health Outcomes Partnership: A Demonstration Project, 1997
Learn how to select diseases for Medicaid disease management from this 18-page NPC booklet written by Judith Jones, the Degge Group. See what Virginia considered before selecting asthma as its first targeted intervention. Fact sheet available.
|
